Methylenetetrahydrofolate reductase (MTHFR) C677T and A1298C polymorphisms and breast cancer in South Indian population

International Journal of Cancer Research

Volumn 2, Issue 2, 2006, Pages 143-151

  Kalyankumar, Ch ^a,b   Jamil, Kaiser ^b  

^a UNIVERSITY OF MYSORE   (India)

^b Bhagawan Mahavir Medical Research Center   (India)

Author keywords

Association; Breast cancer; India; MTHFR

Indexed keywords

METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2);

ADULT; ARTICLE; BLOOD SAMPLING; BREAST BIOPSY; BREAST CANCER; CANCER RISK; CANCER SUSCEPTIBILITY; CASE CONTROL STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DNA ISOLATION; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENE IDENTIFICATION; GENE MUTATION; GENETIC VARIABILITY; GENOME ANALYSIS; GENOTYPE; HISTOPATHOLOGY; HUMAN; INDIA; MAJOR CLINICAL STUDY; MAMMOGRAPHY; POLYMERASE CHAIN REACTION; POPULATION RESEARCH; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

EID: 33646433711     PISSN: 18119727     EISSN: 18119735     Source Type: Journal    
DOI: 10.3923/ijcr.2006.143.151     Document Type: Article

References (30)

1. Beaudet, A.L. and W.S. Sly, 1995. The metabolic and molecular bases of inherited disease. New York, NY: McGraw-Hill Book Company, 31: 11-28.
2. Campbell, I.G., S.W. Baxter, D.M. Eccles and D.Y. Choong, 2002. Methylenetetrahydrofolate reductase polymorphism and susceptibility to breast cancer. Breast Cancer Res., 4:R14.
3. Cheng, P., C. Schmutte, K.F. Cofer, J.C. Felix, M.C. Yu and L. Dubeau, 1997. Alterations in DNA methylation are early, but not initial, events in ovarian tumorigenesis. Br. J. Cancer, 75: 396-402.
4. Deloughery, T.G., A. Evans, A. Sadeghi, J. McWilliams, W.D. Henner, L.M.Jr. Taylor and R.D. Press, 1996. Common mutation in methylenetetrahydrofolate reductase. Correlation with homocysteine metabolism and late-onset vascular disease. 94: 3074-3078.
5. Dianov, G.L., T.V. Timchenko, O.I. Sinitsina, A.V. Kuzminov, O.A. Medvedev and R.L. Salganik, 1991. Repair of uralic residues closely spaced on the opposite strands of plasmid DNA results in double-strand break and deletion formation. Mol. Gen. Genet, 225: 448-452.
6. Esteller, M., A. Garcia, J.M. Martinez-Palones, J. Xercavins and J. Reventos, 1997. Germ line polymorphisms in cytochrome-P450 1A1 (C4887 CYP1A1) and mothylenetetrahydrofolate reductase (MTHFR) genes and endometrial cancer susceptibility. Carcinogenesis, 18: 2307-2311.
7. Ergul, E.A., N. Z. Utkan and Z. Cant, 2003. Polymorphism in the MTHFR gene is associated with Breast cancer. Tumor Biology, 24: 286-290.
8. Frosst, P., H.J. Blom, R. Milos, P. Goyette, C.A. Sheppard, R.G. Matthews, G.J. Boers, M. den Heijer, L.A. Kluijtmans and L.P. van den Heuvel et al., 1995. A candidate genetic risk factor for vascular disease: A common mutation in methylenetetrahydrofolate reductase. Nat. Genet, 10: 111-113.
9. Gershoni-Baruch, R., E. Dagan, D. Israeli, L. Kasinetz, E. Kadouri and E. Friedman, 2000. Association of the C677T polymorphism in the MTHFR gene with breast and/or ovarian cancer risk in Jewish women. Eur. J. Cancer, 36: 2313-2316.
10. Goyette, P., J.S. Sumner, R. Milos, A.M. Duncan, D.S. Rosenblatt, R.G. Matthews and R. Rozen, 1994. Human methylenetetrahydrofolate reductase: Isolation of cDNA, mapping and mutation identification. Nat. Genet, 7: 551-554.
11. Jencks, D.A. and R.G. Mathews, 1987. Allosteric inhibition of methylenetetrahydrofolate reductase by adenosylmethionine. Effects of adenosylmethionine and NADPH on the equilibrium between active and inactive forms of the enzyme and on the kinetics of approach to equilibrium. J. Biol. Ch. 262: 2485-2493.
12. Jacob, R.A., D.M. Gretz, P.C. Taylor, S.J. James, I.P. Pogribny. B.J. Miller, S.M. Henning and M.E. Swendseid, 1998. Moderate folate depletion increases plasma homocysteine and decreases lymphocyte DNA methylation in postmenopausal women. J. Nutr., 128: 1204-1212.
13. Kim, Y.I., I.P. Pogribny, A.G. Basnakian, J.W. Miller, J. Selhub, S.J. James and J.B. Mason, 1997. Folate deficiency in rats induces DNA strand breaks and hypomethylation within the p53 tumor suppressor gene. Am. J. Clin. Nutr., 65: 46-52.
14. Kundu, T.K. and M.R. Rao, 1999. CpG islands in chromatin organization and gene expression. J. Biochem., 125: 217-222.
15. Sohn, K.J., R. Croxford, Z. Yates, M. Glascock and Y. Kim, 2004. Effect of Methylenetetrahydrofolate reductase C677T polymorphism on chemo sensitivity of colon and breast cancer cells to 5- Fluorouracil and Methotrexate. J. Natl. Cancer Inst., 9: 134-144.
16. Lengauer, C., K.W. Kinzler and B. Vogelstein, 1997. DNA methylation and genetic instability in colorectal cancer cells. Proced. Natl. Acad. Sci. USA, 94: 2545-2550.
17. Merchand, L.L., L.R.W. Laurence, N. Kolonel and B.E. Henderson, 2005. The MTHFR C677T polymorphism in colorectal cancer: The multi ethical cohort study. Cancer Epid. Biomar. Prev., 14: 1198-1203.
18. Merchand, L.L., C.A. Haiman R.L.L. Wilkens, N. Kolonel and B.E. Henderson, 2004. MTHFR polymorphism, Diet, HRT and Breast Cancer Risk. The Multiethenic Cohort Study. Cancer Epid. Biomar. Prev., 13: 2071-2077.
19. Matthews, R.G. and R. Rozen, 1994. Human methylenetetrahydrofolate reductase: isolation of cDNA, mapping and mutation identification. Nat. Genet, 7: 551-554.
20. Matthews, R.G., M.A. Vanonim and J.F. Hainfeld et al. 1984. Methylenetetrahydrofolate reductase. Evidence for spatially distinct subunit domains obtained by scanning transmission electron microscopy and limited proteolysis. J. Biol. Chem., 259: 11647-50.
21. Miller, S.A., D.D. Dykes and H.F. Polesky, 1988. DNA from human nucleated cells. A simple salting out procedure for extracting. Nucleic Acids Res., 16: 1215.
22. Semenza, J.C., R.J. Delfino, A. Ziogas and H. Anton-Culver, 2003. Breast cancer risk and methylenetetrahydrofolate reductase polymorphism. Breast Cancer Res. Treat, 77: 217-223.
23. Sharp, L., J. Little, A.C. Schofield, E. Pavlidou, S.C. Cotton, Z. Miedzybrodzka, J.O. Baird, N.E. Haites, S.D. Heys and D.A. Grubb, 2002. Folate and breast cancer: The role of polymorphisms in methylenetetrahydrofolate reductase (MTHFR). Cancer Lett, 181: 65-71.
24. Stampfer, M.J., E. Giovannucci, C. Artigas, D.J. Hunter, C. Fuchs, W.C. Willett, J. Selhub, C.H. Hennekens and R. Rozen, 1997. Methylenetetrahydrofolate reductase polymorphism, dietary interactions and risk of colorectal cancer. Cancer Res., 57: 1098-1102.
25. Stern, L.L., J.B. Mason, J. Selhub and S.W. Choi, 2000. Genomic DNA hypomethylation, a characteristic of most cancers, is present in peripheral leukocytes of individuals who are homozygous for the C677T polymorphism in the methylenetetrahydrofolate reductase gene. Cancer Epid. Biomar. Prev., 9: 849-853
26. Stewart, B. and P. Kleihues, 2003. World Cancer Report. IARC Press, Lyon.
27. Slattery, M.L., J.D. Potter, W. Samowitz, D. Schaffer and M. Leppert, 1999. Methylenetetrahydrofolate reductase, diet and risk of colon cancer. Cancer Epid. Biomar. Prev., 8: 513-518.
28. Van der Put, N.M., F. Gabreels, E.M. Stevens, J.A. Smeitink, F.J. Trijbels, T.K. Eskes, L.P. van den Heuvel and H.J. Blom, 1998. A second common mutation in the methylenetetrahydrofolate reductase gene: An additional risk factor for neural-tube defects? Am. J. Hum. Genet., 62: 1044-1051.
29. Weisberg, I., P. Tran, B. Christensen, S. Sibani and R. Rozen, 1998 A second genetic polymorphism in methylenetetrahydrofolate reductase (MTHFR) associated with decreased enzyme activity. Mol. Genet. Metab., 64: 169-172.
30. Wiernels, J.L., R.N. Smith and G.M. Taylor, 2001. Methylenetetrahydrofolate reductase (MTHFR) polymorphisms and risk of molecularly defined subtypes of childhood acute leukemia. Proced. Natl. Acad. Sci., USA, 98: 4004-4009.